Cellect Biotechnology Ltd. - ADR
APOP
Market Cap$129.02M
Close$
$13.51
2.6% upside
Current Fair Value
2.6% upsideUndervalued by 2.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $129.02 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-66902.5 |
| Beta | 1.88 |
| Outstanding Shares | 586,331 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 41.65 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Cellect Biotechnology Ltd.
CEO: Shai Yarkoni